This occurs alters alpha-oxidation pathway which may potentially be a targeted pathway for future studies, Moreover, PPAR signalling, pyruvate metabolism, butanoate metabolism, and RAS may be the key pathway regulated by PHYH in ccRCC. Here, PPARA is linked to nonpapillary renal cell carcinoma.